ADES Stock Recent News Advanced Emissions Solutions Inc (ADES)

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 12:05 AM

Advanced Emissions Solutions Inc (ADES) 20.18 $ADES

CECO Environmental Tops Q3 Earnings Led by Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:40AM CST
CECO Environmental Corp. (CECE) declared third-quarter 2014 adjusted earnings of 28 cents per share, which came 7.7% above the Zacks Consensus Estimate of 26 cents per share.
VTNR: 4.99 (-0.22), CECE: 14.54 (-0.06), HCCI: 17.77 (-1.22), ADES: 20.18 (-0.37)

Calgon Carbon's Q3 Earnings and Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 9:10AM CST
Calgon Carbon's (CCC) earnings and revenues missed the Zacks Consensus Estimate in the third quarter.
BIN: 30.29 (+0.30), HCCI: 17.77 (-1.22), CCC: 21.22 (+0.05), ADES: 20.18 (-0.37)

Advanced Emissions Solutions Engages Moelis & Company LLC as Financial Advisor to Assist in Evaluating Opportunities for Expected Cash Flows
GlobeNewswire - Mon Nov 10, 7:43AM CST
Advanced Emissions Solutions, Inc. (Nasdaq:ADES) (the "Company" or "we"

today announced that the Company has retained Moelis & Company LLC ("Moelis"

(NYSE:MC) as exclusive financial advisor. Moelis is working with the Finance Committee ("Committee"

of the Board of Directors, which was formed earlier this year to evaluate opportunities around the most advantageous use of our future cash flows in order to maximize stockholder value. The Committee, with the support of Moelis, will continue to evaluate options, which may include alternative corporate structures, establishing dividend policies, or tax efficient investments.
MC: 35.01 (-0.08), ADES: 20.18 (-0.37)

Hyster-Yale Beats Q3 Earnings on Lower Costs, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 11:30AM CST
Hyster-Yale's (HY) third-quarter earnings beat the Zacks Consensus Estimate.
HY: 78.23 (+1.05), APOG: 44.63 (+0.57), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

Thermon Group Holdings (THR) Catches Eye: Stock Jumps 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:30AM CST
Thermon Group Holdings, Inc. (THR) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
ROP: 157.25 (+0.51), THR: 25.39 (+0.20), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

Advanced Emissions Solutions Provides Refined Coal Update
GlobeNewswire - Wed Nov 05, 6:47AM CST
-- Clean Coal Solutions Leases Additional RC Facility
ADES: 20.18 (-0.37)

Rexnord Expands Energy Business in India with Euroflex Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 6:05PM CST
Diversified machinery product manufacturer Rexnord Corporation (RXN) has inked a definitive agreement to acquire Euroflex Transmissions for an undisclosed amount.
CUI: 7.02 (-0.04), RXN: 26.72 (+0.23), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

Terex Misses on Q3 Earnings, Shares Fall on Weak View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 10:40AM CST
Terex's (TEX) third-quarter earnings missed the Zacks Consensus Estimate.
MNTX: 11.45 (+0.05), TEX: 28.18 (-0.08), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

Lincoln Electric Beats Q3 Earnings on Top-line Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:00AM CST
Lincoln Electric's (LECO) third-quarter revenues and earnings beat the Zacks Consensus Estimate.
APOG: 44.63 (+0.57), LECO: 73.75 (-0.20), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

AptarGroup Rises on Record Q3, Beats Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:31AM CST
AptarGroup's (ATR) third-quarter earnings beat the Zacks Consensus Estimate by a penny.
MWV: 44.14 (-0.40), ATR: 64.83 (-0.12), ADES: 20.18 (-0.37), AOS: 53.17 (+0.25)

Progressive Waste Solutions (BIN) Jumps: Stock Rises 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:32AM CDT
Progressive Waste Solutions Ltd. (BIN) was a big mover last session, as the company saw its shares rise more than 7% on the day.
MEA: 0.47 (-0.03), BIN: 30.29 (+0.30), HCCI: 17.77 (-1.22), ADES: 20.18 (-0.37)

Ball Corporation Tops Q3 Earnings on Global Cost Containment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 2:00PM CDT
Ball Corporation's (BLL) third-quarter 2014 earnings beat the Zacks Consensus Estimate.
ADEP: 8.59 (-0.07), CCK: 47.54 (-0.48), BLL: 64.24 (-0.92), ADES: 20.18 (-0.37)

Weakness Seen in Owens-Illinois (OI): Stock Tumbles 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:59AM CDT
Shares of Owens-Illinois fell over 9% last session and witnessed negative revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ADEP: 8.59 (-0.07), OI: 25.46 (-0.09), APOG: 44.63 (+0.57), ADES: 20.18 (-0.37)

Owens-Illinois Beats on Q3 Earnings, Slashes 2014 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:40AM CDT
Owens-Illinois' (OI) third-quarter earnings beat the Zacks Consensus Estimate.
ADEP: 8.59 (-0.07), OI: 25.46 (-0.09), STZ: 92.88 (-0.49), ADES: 20.18 (-0.37)

Trex Co. Inc. (TREX) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 8:11AM CDT
Trex Co. Inc. (TREX) was a big mover last session, as the company saw its shares rise over 6% on the day.
PGTI: 9.70 (+0.01), TREX: 42.82 (-0.09), AIG: 53.90 (-0.60), ADES: 20.18 (-0.37)

Avery Dennison (AVY) Q3 Earnings Up Y/Y, Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 12:33PM CDT
Avery's (AVY) third-quarter 2014 earnings beat the Zacks Consensus Estimate.
USTR: 42.75 (-0.07), AVY: 47.54 (-0.55), ADES: 20.18 (-0.37), ALG: 44.61 (-0.18)

Silgan's Q3 Earnings in Line with Estimates, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 11:30AM CDT
Silgan's (SLGN) third-quarter 2014 earnings were in line the Zacks Consensus Estimate.
CCK: 47.54 (-0.48), SLGN: 49.13 (-0.65), ADES: 20.18 (-0.37), ALG: 44.61 (-0.18)

Bemis Company's Q3 Earnings in Line, Trims 2014 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:40AM CDT
Bemis' (BMS) third-quarter earnings in line with the Zacks Consensus Estimate.
SON: 40.67 (-0.28), ADES: 20.18 (-0.37), BMS: 38.46 (-0.58), ALG: 44.61 (-0.18)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:35PM CDT

MXIM: 29.57 (+0.27), GHL: 46.48 (-0.46), HBHC: 34.86 (-0.14), HWAY: 15.17 (+0.03), DV: 48.72 (+0.25), FET: 27.16 (+0.50), CLNE: 6.45 (+0.06), ADES: 20.18 (-0.37), FII: 30.84 (-0.17), LOGM: 52.19 (+0.38), MSFT: 49.58 (-0.03), BLDR: 5.95 (+0.11), CLMS: 14.10 (+0.09), PDFS: 13.82 (-0.18), IM: 26.94 (+0.19), NCR: 28.25 (+0.01), EW: 124.50 (-0.05), POL: 36.68 (-0.49), DLB: 43.46 (+0.30), HUBG: 36.93 (-0.44), PFPT: 43.86 (-0.35), PFG: 52.86 (-0.39), NTGR: 34.59 (+0.30), PCCC: 23.35 (+0.02), FSL: 19.67 (+0.31), CTCT: 34.64 (+0.08), BMRN: 82.85 (-5.07), RUBI: 13.32 (+0.13), OLN: 25.24 (-0.05), ALTR: 35.25 (+0.39), CB: 101.25 (-0.22), N: 109.06 (+1.15), MTSN: 2.73 (-0.01), JNPR: 20.99 (+0.54), MXWL: 11.20 (+0.39), GIMO: 14.46 (+0.18), INFA: 36.66 (+0.21), ELY: 7.92 (-0.08), P: 21.51 (+3.06), RMD: 52.37 (+0.38), CNMD: 41.96 (-0.36), BJRI: 46.03 (-0.53), PEB: 41.84 (-0.24), CERN: 64.31 (-0.22), CBI: 54.19 (+0.68), AMZN: 327.82 (+11.34), ECHO: 27.41 (-0.45), ALGN: 54.27 (-0.44), LSCC: 6.54 (+0.02), DECK: 91.79 (+1.11), CYN: 78.61 (-0.47), PACB: 6.80 (-0.13), QLIK: 30.10 (+0.49), CPWR: 10.17 (+0.01), FLS: 66.13 (+0.37), BAS: 11.59 (+0.57), KLAC: 80.33 (+0.89)

Astec (ASTE) Lags Q3 Earnings on Lack of Highway Bill - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 9:10AM CDT
Astec's (ASTE) third-quarter earnings missed the Zacks Consensus Estimate.
HEES: 36.72 (-0.46), ADES: 20.18 (-0.37), ASTE: 38.02 (-0.20), ALG: 44.61 (-0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Micropos Medical's Push in High-Precision Radiotherapy

Micropos Medical's Bold Steps into Radiotherapy Let's put a spotlight on a niche that's crying for attention: Micropos Medical is making waves in how we treat prostate cancer. They're leveraging technology with their Raypilot System, and they're partnering with the big guns at Johns Hopkins Medicine. Think about it — five patients in the U.S. are already seeing how this...

Metals Producers Rise Despite Futures Dip: Election Day Buzz

Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...

Kaolin Market Surges to $8.89B by 2031: Key Trends

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

PASCO scientific Appoints David Lopez as New CEO

New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...

Scage Future's Next Leap: Mining with Autonomy

Scage Future Drives Change with NCMCC Partnership Ever hear a platoon of autonomous trucks gearing up, ready to redefine the mining sector? That's exactly what’s brewing between Scage Future and China Huaye Group Co., Ltd. (NCMCC) from the latest update right out of Nanjing. Breaking Down the Deal They've slapped their signature on a non-binding agreement as of...

SecureSpace Expands into Dallas-Fort Worth Market

A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...

WeSalute's 'Heroes Meet Heroes' Unites Military, Athletes

Every now and then, something stirs the soul in a way that neither Wall Street nor Main Street quite can. The 14th annual 'Heroes Meet Heroes' event by WeSalute is poised to do just that. Celebrating Service Through Shared Experiences WeSalute has been a cornerstone for veteran recognition for over two decades, fostering a sense of unity between military service members...

Silvercorp Updates El Domo Budget Amid Challenges

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....